These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31290809)

  • 21. Optimizing quality of life in perimenopause: lessons from the East.
    Wang X; Ran S; Yu Q
    Climacteric; 2019 Feb; 22(1):34-37. PubMed ID: 30407085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in an office practice of menopause in the last 25 years.
    Nachtigall L
    Menopause; 2018 Apr; 25(4):361-362. PubMed ID: 29570561
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone-replacement therapy: current thinking.
    Lobo RA
    Nat Rev Endocrinol; 2017 Apr; 13(4):220-231. PubMed ID: 27716751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women's Health Initiative data--what were the real conclusions and how will these studies impact the pelvic floor?
    Karram MM
    Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(1):1-2. PubMed ID: 15565353
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipid guidelines - are we heading in the right direction?
    Fenton A; Panay N
    Climacteric; 2014 Apr; 17(2):107-8. PubMed ID: 24628004
    [No Abstract]   [Full Text] [Related]  

  • 26. Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.
    McSweeney JC; Rosenfeld AG; Abel WM; Braun LT; Burke LE; Daugherty SL; Fletcher GF; Gulati M; Mehta LS; Pettey C; Reckelhoff JF;
    Circulation; 2016 Mar; 133(13):1302-31. PubMed ID: 26927362
    [No Abstract]   [Full Text] [Related]  

  • 27. [Does menopause hormone therapy reduce the risk of chronic diseases?].
    Blümel JE; Arteaga E
    Rev Med Chil; 2018 Dec; 146(10):1170-1174. PubMed ID: 30724981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The view of The International Menopause Society on the Women's Health Initiative.
    Schneider HP;
    Climacteric; 2002 Sep; 5(3):211-6. PubMed ID: 12419078
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
    Lukes A
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are the concerns about custom-compounded "bioidentical" hormone therapy?
    Pinkerton JV
    Menopause; 2014 Dec; 21(12):1298-300. PubMed ID: 25387347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal hormone therapy and sleep-disordered breathing: evidence for a healthy user bias.
    Mirer AG; Peppard PE; Palta M; Benca RM; Rasmuson A; Young T
    Ann Epidemiol; 2015 Oct; 25(10):779-84.e1. PubMed ID: 26358364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women's Health Initiative Trials.
    Minami CA; Freedman RA
    JAMA; 2020 Jul; 324(4):347-349. PubMed ID: 32720989
    [No Abstract]   [Full Text] [Related]  

  • 33. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association.
    Hirsch AT; Allison MA; Gomes AS; Corriere MA; Duval S; Ershow AG; Hiatt WR; Karas RH; Lovell MB; McDermott MM; Mendes DM; Nussmeier NA; Treat-Jacobson D; ; ; ; ; ;
    Circulation; 2012 Mar; 125(11):1449-72. PubMed ID: 22343782
    [No Abstract]   [Full Text] [Related]  

  • 34. Termination of the oestrogen-alone arm of the Women's Health Initiative.
    Stevenson J; Rees M; Marsden J
    J Br Menopause Soc; 2004 Jun; 10(2):47, 59. PubMed ID: 15759323
    [No Abstract]   [Full Text] [Related]  

  • 35. The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women.
    Hamoda H; Panay N; Pedder H; Arya R; Savvas M
    Post Reprod Health; 2020 Dec; 26(4):181-209. PubMed ID: 33045914
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.
    Honebrink A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):619-41. PubMed ID: 16083332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversial issues in climacteric medicine (I) Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop, 13-16 October 2000, Royal Society of Medicine, London, UK.
    Genazzani AR
    Maturitas; 2001 May; 38(3):263-71. PubMed ID: 11358643
    [No Abstract]   [Full Text] [Related]  

  • 38. [Menopausal hormone therapy: internal-endocrine point of view].
    Gärtner R; Albrich W
    Dtsch Med Wochenschr; 2021 Jan; 146(1):41-47. PubMed ID: 33395726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capsule commentary on Gerber et al., hormone therapy use in women veterans accessing veterans health administration care: a national cross-sectional study.
    Schwarz EB
    J Gen Intern Med; 2015 Feb; 30(2):237. PubMed ID: 25387441
    [No Abstract]   [Full Text] [Related]  

  • 40. Negotiating competing discourses: the decision to take menopausal hormone therapy following surgical menopause.
    Burrell B; Valledor V; Crowe M; Whitehead L
    Women Health; 2010 Sep; 50(6):527-43. PubMed ID: 20981635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.